0000899243-17-027190.txt : 20171121
0000899243-17-027190.hdr.sgml : 20171121
20171121191704
ACCESSION NUMBER: 0000899243-17-027190
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171121
FILED AS OF DATE: 20171121
DATE AS OF CHANGE: 20171121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILVERSTEIN JONATHAN
CENTRAL INDEX KEY: 0001171005
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38293
FILM NUMBER: 171218125
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: scPharmaceuticals Inc.
CENTRAL INDEX KEY: 0001604950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465184075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2400 DISTRICT AVENUE
STREET 2: SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01830
BUSINESS PHONE: 617-517-0730
MAIL ADDRESS:
STREET 1: 2400 DISTRICT AVENUE
STREET 2: SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01830
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-21
1
0001604950
scPharmaceuticals Inc.
SCPH
0001171005
SILVERSTEIN JONATHAN
C/O SCPHARMACEUTICALS INC
2400 DISTRICT AVENUE, SUITE 310
BURLINGTON
MA
01830
1
0
0
0
Common Stock
2017-11-21
4
C
0
2576532
A
2576532
I
By: OrbiMed Private Investments VI, L.P.
Series B Preferred Stock
2017-11-21
4
C
0
18500000
0.00
D
Common Stock
2576532
0
I
By: OrbiMed Private Investments VI, L.P.
Represents the total number of shares of Common Stock received by OrbiMed Private Investments VI, L.P. ("OPI VI"), upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
The shares of Series B Preferred Stock are held of record by OPI VI. OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OPI VI, and OrbiMed Advisors LLC ("Advisors"), a registered adviser under the Investment Advisers Act of 1940, as amended, is the sole managing member of GP VI. Jonathan Silverstein, a natural person, is a managing member of, and holder of a controlling interest in Advisors. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose.
All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017 and had no expiration date.
/s/ Courtney Gaughan, Attorney-in-Fact
2017-11-21